One week until Agents in Practice. See CluePoints’ agentic AI capabilities live, where they’re headed next, and how human oversight and governance shape the approach. 📅 Nov 2 | ⏰ 10:00 AM ET Register: hubs.ly/Q04CgK0g0 #AgenticAI #ClinicalTrials

Which trial signals matter, and who should act? Leaders from CluePoints, IQVIA and CRScube explore the AI-powered Clinical Data Control Tower and the rise of the “Data-Pilot.” 📅 Nov 10 | 10:00 AM ET Register: hubs.ly/Q04BLbsn0+

Agentic AI can help clinical teams move from data to decisions. Responsible adoption takes governance. Usama Dar and Richard Young share a live demo of CluePoints’ agentic capabilities and what’s next. 📅 Nov 2, 10 AM ET Register: hubs.ly/Q04Bh7C80 #AgenticAI #RBQM

Thank you to our speakers and moderators for sharing their perspectives at RBQMLive 2026. All four sessions are now available on demand. → Watch at your own pace and share with your team: hubs.ly/Q04z_CFG0 #RBQMLive #RBQM

SCOPE Europe starts today in Barcelona! 🇪🇸 Stop by Booth 59 to meet CluePoints and enter our giveaway to win Bose QuietComfort Headphones! 🎧 Don’t miss Frederic Blais on RBQM & Change Management today, 3:55–4:20pm CEST, RBQM Track. #SCOPEEurope #RBQM

Next week, we’re exhibiting at the Veeva R&D and Quality Summit in Boston. Come talk RBQM with the CluePoints team. 📅 Oct 20-21 📍 Boston, MA #VeevaSummit #RBQM

RBQMLive 2026 is two weeks out. Oct 7-8, virtual. Four sessions on ICH E6(R3) maturity, RBQM's business case, AI in clinical ops, and quality by design. Register today: hubs.ly/Q04y7WbX0

Up to 23x ROI. Phase durations shortened by up to 19%. One of the first peer-reviewed studies on the financial return of RBQM, presented by Tufts CSDD and CluePoints, is now available to watch on demand. Watch here: hubs.ly/Q04xdWKF0

One day left to register. Tomorrow, Tufts CSDD and CluePoints present one of the first peer-reviewed studies on the financial value of RBQM: up to 23x ROI and 19% shorter phases across 18 oncology trials. Thu, Sept 10 | 9 AM ET Reserve your spot: hubs.ly/Q04x174s0

Three new AI-driven capabilities for clinical data review are live: IQD, MSR and IMC. Co-innovated with a top 10 pharma. We're at #SCDM2026 in Raleigh next week. Booth 502 for live demos of all three. hubs.ly/Q04wv8Xq0

One week to go. Tufts CSDD and CluePoints go live September 10 with newly published research quantifying the financial value of RBQM. → Up to 23x ROI → Phase durations reduced by up to 19% 9:00 AM ET. Register: hubs.ly/Q04wg_-J0

Boston, here we come! CluePoints is exhibiting at DPHARM 2026. Stop by Booth #121 to talk clinical data review and oversight with our team. 📅 September 15–16  📍 Boston, MA | Booth #121  #DPHARM2026 #CluePoints #ClinicalInnovation

We're heading to SCDM 2026 in Raleigh. Stop by CluePoints Booth #502 to talk clinical data review and RBQM with our team. 📍 Booth #502 | Raleigh, NC  📅 September 15–17  #SCDM2026 #CluePoints #RBQM

The RBQMLive 2026 agenda is now live. Four sessions on operational maturity, proving RBQM value, trusted AI, and predicting risk before first patient in. Oct 7-8. Virtual and free to attend. Register today: hubs.ly/Q04vcnPL0

The launch is heading to the rooftop! Join CluePoints at Urban Oak Rooftop Bar on Tues, Sept 15 as we toast the arrival of three new products shaping the future of Clinical Data Review. 📍 Urban Oak Rooftop Bar | 🗓️ Tues Sept 15, 7:30–10:30 PM Register: hubs.ly/Q04tJ5kM0

Making the business case for RBQM? Join CluePoints + Tufts CSDD for new peer-reviewed evidence on ROI and clinical development impact. Have a question? Submit it when you register. Register now: hubs.ly/Q04sYDcD0 #RBQM #ClinicalTrials #Pharma #CRO

"Prove the ROI" is where most RBQM conversations stall. For years the answer was "we believe it helps." On Sept 10, we bring the data: new peer-reviewed research quantifying RBQM's financial return. Save your seat: hubs.ly/Q04s5DPW0

We're thrilled to welcome Marty Magazzolo as CluePoints' new Chief Commercial Officer. Marty brings 30+ years of life sciences and healthcare tech leadership to our global commercial team as we scale RBQM and data quality oversight. Welcome, Marty! hubs.ly/Q04qQt130

RBQM-enabled trials: up to 23x ROI and 8–19% shorter clinical phases. The first peer-reviewed study quantifying RBQM's financial return, from CluePoints & Tufts CSDD, based on 18 real-world oncology trials. Read here: hubs.ly/Q04nWjxh0 #RBQM #ClinicalTrials #ICHE6R3

Regulators used to ask: Did the review happen? Now: Was it timely? Proportionate? Justified? Traceable? Medical & Safety Review hasn't changed. The expectations have. See what a modern, audit-ready workflow looks like: hubs.ly/Q04nWt2-0.. #LifeSciences #ICHE6R3